| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ligand Pharmaceuticals Inc (LGND) has 11 insiders with recent SEC Form 4 filings, including 1 buy and 23 sells. LGND is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 161.3K | $35.72M | - | |
| Dir | 44.0K | $9.74M | - | |
| Dir | 33.8K | $7.48M | - | |
| Dir | 32.8K | $7.25M | - | |
| Other | 30.8K | $6.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2024 | Korenberg Matthew E | President &COO | Sale+OE | 16,047 | $102.35 | $1,642,358.76 | -7.1% | +14.2% | +71.2% | |
| Sep 20, 2024 | Espinoza Octavio45 | Chief Financial Officer | Sell | 1,275 | $103.94 | $132,518.19 | -1.7% | +10.8% | +62.0% | |
| Aug 28, 2024 | Reardon Andrew | CLO &Secretary | Sale+OE | 1,500 | $106.39 | $159,590.55 | -6.2% | +16.7% | +50.1% | |
| Aug 26, 2024 | Korenberg Matthew E | President &COO | Sell | 18,858 | $105.34 | $1,986,420.12 | -6.0% | +14.7% | +51.9% | |
| Aug 9, 2024 | Korenberg Matthew E | President &COO | Sell | 18,245 | $98.50 | $1,797,132.50 | -21.1% | +29.7% | +49.8% | |
| Aug 8, 2024 | Davis Todd C77 | Chief Executive Officer | Buy | 2,500 | $97.39 | $243,480.50 | +2.1% | +20.6% | +54.8% | |
| May 17, 2024 | Espinoza Octavio45 | Chief Financial Officer | Sale+OE | 13,293 | $86.26 | $1,146,703.87 | -12.6% | +19.8% | +21.5% | |
| May 14, 2024 | Korenberg Matthew E | President &Chief Operating | Sell | 17,598 | $84.99 | $1,495,740.49 | -6.0% | +16.8% | +23.2% | |
| May 9, 2024 | Reardon Andrew | Chief Legal Officer & | Sale+OE | 10,000 | $83.04 | $830,449.00 | -31.1% | +8.4% | +21.3% | |
| May 9, 2024 | Gray Nancy Ryan | Director | Sell | 934 | $83.20 | $77,713.38 | -14.2% | +8.4% | +21.3% |